FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131577029> ?p ?o ?g. }

• W2131577029 endingPage "999" @default.
• W2131577029 startingPage "994" @default.
• W2131577029 abstract "Objectives: Failure to prevent secondary infectious complications in acute necrotizing pancreatitis (ANP) is attributable in part to the limited penetration of antimicrobial drugs. As newer quinolones are particularly attractive owing to their antimicrobial activity, for the first time we studied the penetration of moxifloxacin into pancreatic tissue in patients. Patients and methods: In this prospective, non-comparative clinical trial, 60 patients undergoing elective pancreas resection received a single oral or intravenous (iv) dose of 400 mg moxifloxacin for perioperative antimicrobial prophylaxis. The concentration of moxifloxacin was measured in samples taken from blood and from pancreatic tissue at the beginning and at the end of resection. Results: Mean moxifloxacin concentrations in pancreatic tissue following iv or oral administration were 3.1 ± 0.9 and 2.7 ± 1.4 mg/kg at 3–3.7 h post-dose (first sampling) and 3.6 ± 1.5 and 3.1 ± 1.8 mg/kg at 4.3–5.3 h post-dose (second sampling), respectively. Corresponding mean plasma concentrations of moxifloxacin were 1.8 ± 0.5 and 1.2 ± 0.6 mg/L (first sampling) and 1.5 ± 0.4 and 1.0 ± 0.5 mg/L (second sampling), respectively. From first to second sampling, the mean tissue-to-plasma ratios varied from 1.8 ± 0.6 to 2.6 ± 1.2 (iv) and from 2.4 ± 0.8 to 3.1 ± 1.2 (oral). Pancreatic tissue concentrations of moxifloxacin exceeded the MIC90 for the relevant pathogens covered by moxifloxacin for at least 5 h after dosing. Conclusions: Moxifloxacin has been demonstrated to penetrate efficiently into human pancreatic tissue following iv or oral administration. From a pharmacological perspective, moxifloxacin appears to be promising for prophylaxis and treatment of local pancreas infections. Whether it is beneficial in the prevention and therapy of infectious complications in patients with ANP should be investigated in a controlled clinical trial." @default.
• W2131577029 created "2016-06-24" @default.
• W2131577029 creator A5000154147 @default.
• W2131577029 creator A5005298502 @default.
• W2131577029 creator A5032515123 @default.
• W2131577029 creator A5035927759 @default.
• W2131577029 creator A5058360849 @default.
• W2131577029 creator A5060156253 @default.
• W2131577029 creator A5064235239 @default.
• W2131577029 date "2006-09-06" @default.
• W2131577029 modified "2023-09-27" @default.
• W2131577029 title "Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose" @default.
• W2131577029 cites W1501729477 @default.
• W2131577029 cites W1502372295 @default.
• W2131577029 cites W1917229050 @default.
• W2131577029 cites W1954362633 @default.
• W2131577029 cites W1981823549 @default.
• W2131577029 cites W1983084963 @default.
• W2131577029 cites W1989365814 @default.
• W2131577029 cites W1995003525 @default.
• W2131577029 cites W1995907712 @default.
• W2131577029 cites W1996358882 @default.
• W2131577029 cites W2013009263 @default.
• W2131577029 cites W2013062386 @default.
• W2131577029 cites W2023225822 @default.
• W2131577029 cites W2024217179 @default.
• W2131577029 cites W2059404775 @default.
• W2131577029 cites W2075974548 @default.
• W2131577029 cites W2076165801 @default.
• W2131577029 cites W2083688007 @default.
• W2131577029 cites W2088931574 @default.
• W2131577029 cites W2104711521 @default.
• W2131577029 cites W2128986803 @default.
• W2131577029 cites W2130207536 @default.
• W2131577029 cites W2135888335 @default.
• W2131577029 cites W2139648891 @default.
• W2131577029 cites W2144933920 @default.
• W2131577029 cites W2147229920 @default.
• W2131577029 cites W2148658704 @default.
• W2131577029 cites W2153210236 @default.
• W2131577029 cites W2154269857 @default.
• W2131577029 cites W2161473787 @default.
• W2131577029 cites W2168826887 @default.
• W2131577029 cites W2399550983 @default.
• W2131577029 cites W2410060404 @default.
• W2131577029 doi "https://doi.org/10.1093/jac/dkl353" @default.
• W2131577029 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16956903" @default.
• W2131577029 hasPublicationYear "2006" @default.
• W2131577029 type Work @default.
• W2131577029 sameAs 2131577029 @default.
• W2131577029 citedByCount "29" @default.
• W2131577029 countsByYear W21315770292012 @default.
• W2131577029 countsByYear W21315770292014 @default.
• W2131577029 countsByYear W21315770292016 @default.
• W2131577029 countsByYear W21315770292019 @default.
• W2131577029 countsByYear W21315770292020 @default.
• W2131577029 countsByYear W21315770292021 @default.
• W2131577029 countsByYear W21315770292022 @default.
• W2131577029 countsByYear W21315770292023 @default.
• W2131577029 crossrefType "journal-article" @default.
• W2131577029 hasAuthorship W2131577029A5000154147 @default.
• W2131577029 hasAuthorship W2131577029A5005298502 @default.
• W2131577029 hasAuthorship W2131577029A5032515123 @default.
• W2131577029 hasAuthorship W2131577029A5035927759 @default.
• W2131577029 hasAuthorship W2131577029A5058360849 @default.
• W2131577029 hasAuthorship W2131577029A5060156253 @default.
• W2131577029 hasAuthorship W2131577029A5064235239 @default.
• W2131577029 hasBestOaLocation W21315770291 @default.
• W2131577029 hasConcept C112705442 @default.
• W2131577029 hasConcept C126322002 @default.
• W2131577029 hasConcept C126894567 @default.
• W2131577029 hasConcept C141071460 @default.
• W2131577029 hasConcept C2775967933 @default.
• W2131577029 hasConcept C2777288759 @default.
• W2131577029 hasConcept C2778836808 @default.
• W2131577029 hasConcept C31174226 @default.
• W2131577029 hasConcept C4937899 @default.
• W2131577029 hasConcept C501593827 @default.
• W2131577029 hasConcept C71924100 @default.
• W2131577029 hasConcept C86803240 @default.
• W2131577029 hasConcept C89423630 @default.
• W2131577029 hasConcept C90924648 @default.
• W2131577029 hasConceptScore W2131577029C112705442 @default.
• W2131577029 hasConceptScore W2131577029C126322002 @default.
• W2131577029 hasConceptScore W2131577029C126894567 @default.
• W2131577029 hasConceptScore W2131577029C141071460 @default.
• W2131577029 hasConceptScore W2131577029C2775967933 @default.
• W2131577029 hasConceptScore W2131577029C2777288759 @default.
• W2131577029 hasConceptScore W2131577029C2778836808 @default.
• W2131577029 hasConceptScore W2131577029C31174226 @default.
• W2131577029 hasConceptScore W2131577029C4937899 @default.
• W2131577029 hasConceptScore W2131577029C501593827 @default.
• W2131577029 hasConceptScore W2131577029C71924100 @default.
• W2131577029 hasConceptScore W2131577029C86803240 @default.
• W2131577029 hasConceptScore W2131577029C89423630 @default.
• W2131577029 hasConceptScore W2131577029C90924648 @default.
• W2131577029 hasIssue "5" @default.
• W2131577029 hasLocation W21315770291 @default.

• next